After receiving the ethical approval in Tanzania, NeuroSolve obtained the ethical clearance in Zambia too. The ethical clearance certificate will allow to conduct medical research on Neurocysticercosis also in Zambia.

NeuroSolve is a four-year project funded by the European Commission and EDCTP3, started on May 1, 2023. The African Institutions involved are: University of Dar es Salaam (Tanzania), Sokoine University of Agriculture (Tanzania), University of Zambia (Zambia); the European Institutions are: Universiteit Ghent (Belgium) and R-Evolution Worldwide Srl – Impresa Sociale (Italy), that is also the project Coordinator. NeuroSolve is committed to fight taeniasis/Neurocysticercosis (NCC) disease in Sub-Saharan Africa.

Potrebbe essere un'immagine raffigurante testo

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Soap bubbles against coronavirus in Uganda too !

The “Soap bubbles against coronavirus” initiative is sparking interest in other African nations as well. Indeed a group of young Ugandan decided to come together and create a group of

Third International Conference on Public Health in Africa

The third edition of CPHIA was hosted by the Zambian Ministry of Health and took place from 27th to 30th November 2023 at Mulungushi International Conference Center in Lusaka, Zambia. The topic

African and European multidisciplinary researchers established an integrated consortium to develop a research project on the dengue and Zika viruses affecting Africa and the world

Dengue and Zika viruses are arboviruses primarily transmitted by Aedes mosquitoes. Dengue and Zika infectious disease frequently erupt in tropical and subtropical regions. Globalization coupled with climate change, significantly expedites their worldwide